Defunct Company
Total Trials
21
As Lead Sponsor
As Collaborator
0
Total Enrollment
8,069
NCT00010322
Toremifene With or Without Atamestane in Treating Postmenopausal Women With Metastatic Breast Cancer
Phase: Phase 3
Role: Lead Sponsor
Start: Oct 31, 2000
Completion: May 31, 2001
NCT00044291
Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer
Start: Jun 30, 2002
Completion: Jan 31, 2006
NCT00097045
Omega Interferon Alone or in Combination With Ribavirin in Subjects With Hepatitis C
Phase: Phase 2
Start: Nov 30, 2004
Completion: Dec 31, 2006
NCT00097344
The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer
Start: Dec 31, 2004
Completion: Aug 31, 2006
NCT00267553
Treatment and Survival Continuation Study of Atamestane Plus Toremifene vs Letrozole in Advanced Breast Cancer
Start: Nov 30, 2005
Completion: Jun 30, 2006
NCT00519792
Phase 1b Study of Omega DUROS® in Patients With Chronic Hepatitis C Who Relapsed After Prior Treatment
Phase: Phase 1
Start: Aug 31, 2007
Completion: Mar 31, 2010
NCT01798264
Open Label, 4 Week Study of ITCA 650 in Adults With Type 2 Diabetes
Start: Feb 28, 2009
Completion: May 31, 2009
NCT00943917
Study of ITCA 650 (Exenatide in DUROS) in Subjects With Type 2 Diabetes Mellitus
Start: Aug 31, 2009
Completion: Feb 28, 2011
NCT01455883
A Study to Evaluate ITCA 650 Compared to Glimepiride for the Treatment of Type 2 Diabetes
Start: Feb 28, 2013
Completion: Jul 31, 2014
NCT01455909
A Study to Evaluate ITCA 650 Compared to Sitagliptin for the Treatment of Type 2 Diabetes
NCT01455922
A Study to Evaluate ITCA 650 Compared to Glimepiride as Add on Therapy for the Treatment of Type 2 Diabetes
NCT01455857
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Start: Mar 31, 2013
Completion: Sep 30, 2014
NCT01455896
A Study to Evaluate Cardiovascular Outcomes in Patients With Type 2 Diabetes Treated With ITCA 650
Completion: Mar 31, 2016
NCT01455870
A Study to Evaluate ITCA 650 Compared to Sitagliptin as add-on Therapy for the Treatment of Type 2 Diabetes
Start: May 31, 2013
Completion: Jul 31, 2015
NCT01785771
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
Completion: Jan 31, 2018
NCT02320045
Study to Evaluate Pharmacokinetics of ITCA 650 in Subjects With Renal Impairment Compared to Normal Subjects
Start: Nov 30, 2014
NCT02638805
Study of the Safety and Tolerability of Switching to ITCA 650 in Patients With Type 2 Diabetes Receiving Liraglutide
Start: Dec 31, 2015
Completion: Oct 31, 2017
NCT02641899
Study of the Effects of ITCA 650 on Gastric Emptying and Interaction of ITCA 650 on 4 Commonly Studied Drugs
NCT02641990
Study of the Effect of ITCA 650 on the PK/PD of Oral Contraceptive in Healthy Female Subjects
Completion: Feb 29, 2016
NCT02650479
Study of the Effects of Intravenous Exenatide on Cardiac Repolarization
Start: Jan 31, 2016
Completion: Apr 30, 2016
NCT03060980
Comparison of Efficacy, Safety, and Tolerability of ITCA 650 to Empagliflozin and Glimepiride as add-on Metformin
Start: Mar 3, 2017
Completion: Jan 26, 2018